Chief Strategy Officer

Jonathan Andrus

As Chief Strategy Officer, Jonathan Andrus is responsible for driving the corporate strategic vision, communicating the plan with all those involved, executing the business initiatives, and sustaining implementation efforts. This includes driving important internal initiatives, identifying potential targets for acquisition, and other partnership opportunities to help drive the business forward.

With 25+ years’ experience, Jonathan brings extensive expertise developing eClinical services that integrate data and technology to optimize study execution. Through this experience, Jonathan brings insight and understanding to drive Clinical Ink P&L and quality and compliance across all products and services as well as building relationships and forging strategic industry partnerships.

Jonathan joined Clinical Ink from Bioclinica, where he led the eClinical Solutions Group to develop their current service offerings. Prior to Bioclinica, he worked in pharmaceutical consulting and with CROs focused on quality, data management, and validation.

An active thought leader and presenter, Jonathan formerly served as chair of the Society for Clinical Data Management (SCDM) and currently serves as the society’s treasurer. He is an active member of SCDM, DIA, DTRA, ePRO Consortium, and ASQ.

Jonathan earned his bachelor’s and master’s degrees from Temple University’s College of Liberal Arts and Graduate School of Pharmacy. He is a certified quality auditor (CQA), and clinical data manager (CCDM®), and a veteran of the US Army Military Intelligence Corps.


Contact the source of better clinical trials today.

Request a platform demo or more information.

Schedule a Demo